Sharon C. Miller, MD
Opted out of Medicare from July 2024 to July 2028. Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in West Palm Beach, Florida, licensed in FL and OH, with an NPI issued in November 2006. Their prescriptions cost Medicare Part D more than their services did: $969,324 for 1,992 claims, against $41,214 paid for services in 2024. Dexcom, Inc. was the largest of 5 companies reporting payments in 2025, $200.33 in all, mostly food and beverage.
Overview
| NPI | 1700963378 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | Nov 1, 2006 |
| Last updated in NPPES | May 13, 2024 |
| Certified by provider | May 13, 2024 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | ME105654 | FL |
| Internal Medicine, Endocrinology, Diabetes & Metabolism | 207RE0101X | 35077945 | OH |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Jul 1, 2024 – Jul 1, 2028 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 253 |
|---|---|
| Services billed | 1,091 across 12 procedure codes |
| Paid by Medicare | $41,214 |
Part D prescriptions in 2024
| Prescriptions (claims) | 1,992 · 4,567 30-day fills |
|---|---|
| Patients | 321 |
| Total drug cost | $969,324 |
| Generic share | 34% of claims |
Industry payments (Open Payments)
- 2025$200.33 · 9 payments from 5 companies
- 2024$1,039 · 48 payments from 16 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Dexcom, Inc. | $68.32 | 3 |
| Mannkind Corporation | $65.47 | 3 |
| Sequel Med Tech, LLC | $33.22 | 1 |
| Abbott Laboratories | $16.67 | 1 |
| Insulet Corporation | $16.65 | 1 |
What the 2025 payments were for
- Food and Beverage$200.33 · 9 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in West Palm Beach
- 1215941182
- 1619362290
- 1568857530
- 1437163003
- 1922637420
- 1962637520
- 1003820002
- 1982627907
- 1790125797
- 1215243753
- 1679990584
- 1164477329
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Florida →